DSSRC Refers Health-Related Product and Earnings Claims for Bulavita to FTC
April 20, 2021
MCLEAN, Va., April 20, 2021 /PRNewswire/ — The Direct Selling Self-Regulatory Council (DSSRC) of BBB National Programs referred certain representative product performance and earnings claims to the Federal Trade Commission (FTC) for possible enforcement action after Bulavita, a direct selling company offering muscadine-based health and nutritional supplement products, failed to respond to DSSRC’s inquiry.
At issue in DSSRC’s inquiry are earnings and health-related product performance claims disseminated on the company website and by salesforce members implying that Bulavita products can prevent and/or treat several serious health-related conditions, including COVID-19. In addition, Bulavita salesforce members have made misleading representations in social media posts about income that can be earned as a member of the Bulavita salesforce.